Evidence map›Paper›PMID 40272464›Full record

ArticleNeuroradiology2025

Thrombus perviousness in acute ischemic stroke: a scoping review of methodology, predictive value, and future perspectives.

Gergely Bertalan, Patrick Thurner, Jawid Madjidyar, Miklós Krepuska, Vania Anagnostakou, Anna Kyselyova, Tilman Schubert, Zsolt Kulcsar

Abstract readScoping Review
In one paragraph

Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gergely BertalanUniversity Hospital of Zurich, Zurich, Switzerland. gergely.bertalan@usz.ch.
Patrick ThurnerUniversity Hospital of Zurich, Zurich, Switzerland.
Jawid MadjidyarUniversity Hospital of Zurich, Zurich, Switzerland.
Miklós KrepuskaUniversity Hospital of Zurich, Zurich, Switzerland.
Vania AnagnostakouUniversity Hospital of Zurich, Zurich, Switzerland.
Anna KyselyovaUniversity Hospital of Zurich, Zurich, Switzerland.
Tilman SchubertUniversity Hospital of Zurich, Zurich, Switzerland.
Zsolt KulcsarUniversity Hospital of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThrombus perviousness, depicting the interaction of occlusive clot with contrast media as measured with computed tomography (CT) is a relatively new imaging biomarker in acute ischemic stroke (AIS). This approach holds the potential to tailor revascularization strategies and post-interventional treatments, thereby enhancing functional outcomes. However, its predictive value is not yet conclusive despite its association with several clinical parameters. 

methodsThis scoping review provides a comprehensive overview of 51 articles that explore this issue. It focuses on the analysis of applied methodology in measuring perviousness, the predictive value of perviousness based on available data, and the future perspectives and potentials this biomarker may have in AIS imaging. 

resultsAlthough some data are contradictory, in the vast majority of published studies, pervious thrombi were easier to remove with mechanical thrombectomy, responded better to thrombolytic treatment and showed better functional outcome than impervious thrombi. The methodology of measuring perviousness is not yet standardized, which may lead to inconsistency in the findings. New data on time-resolved (dynamic) perviousness show more promising results and refined characterization of occlusive thrombi in AIS.

Indexed as

Intracranial ThrombosisIschemic StrokeThrombosisTomography, X-Ray ComputedContrast MediaHumansPredictive Value of TestsThrombectomyContrast MediaAcute ischemic strokeClinical outcomeComputed tomographyDynamic perviousnessMechanical thrombectomyThrombus perviousnessThrombus structure

Identifiers

PMID40272464
PMCPMC12125035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.